Related Experiment Video
Updated: Apr 24, 2026

10:11
Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
38.2K
Biotech drugs too little, too late for Ebola outbreak
Nature Biotechnology
|September 10, 2014
Abstract
No abstract available in PubMed .
Related Concept Videos
Cross-reactivity
28.7K
Overview
28.7K
Inhibitors of Viral Protein Synthesis
54
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
54
Drug Products: Biologics, Biosimilars and Interchangeables
366
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
366

